Bracco Industria Chimica Spa, Milan: communications, in particular with the Bracco Delegation of Rome, concerning the health problems that the administration of intravenous metamizole could cause; application for the renunciation of the registration of the medicinal speciality "Sistalgin compositum" ampoules.